REBECCA L GLASER
Medical Practice at Cutlers Trce, Dayton, OH
License number
Florida 104690
Issued Date
Jun 4, 2009
Effective Date
Jan 13, 2015
Expiration Date
Jan 31, 2015
Category
Health Care
Type
Medical Doctor
Address
Address
9530 Cutlers Trce, Dayton, OH 45458
Phone
(937) 885-5455
Organization information
See more information about REBECCA L GLASER at bizstanding.comMillennium Wellness Center - Rebecca L Glaser MD
7740 Washington Vlg Dr STE 110, Dayton, OH 45459
Categories:
Optometrists, Physicians & Surgeons
Phone:
(937) 436-9821 (Phone)
Rebecca L Glaser MD
1997 Miamisburg Centerville Rd, Dayton, OH 45459
Categories:
Physicians & Surgeons
Phone:
(937) 438-1500 (Phone)
Professional information
Dr. Rebecca L Glaser, Dayton OH - MD (Doctor of Medicine)
Specialties:
General Surgery
Address:
Millennium Wellness
228 E Spring Valley Pike, Dayton 45458
(937) 436-9821 (Phone)
228 E Spring Valley Pike, Dayton 45458
(937) 436-9821 (Phone)
Conditions:
Breast Cancer, Breast Lump/Mass
Certifications:
General Surgery, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University Of Cincinnati College Of Medicine
Graduated: 1983
Wright St University
Graduated: 1988
University Of Cincinnati College Of Medicine
Graduated: 1983
Wright St University
Graduated: 1988
Rebecca L Glaser, Dayton OH
Specialties:
Surgeon
Address:
1975 Miamisburg Centerville Rd, Dayton, OH 45459
228 E Spring Valley Pike, Dayton, OH 45458
228 E Spring Valley Pike, Dayton, OH 45458
Education:
University of Cincinnati, College of Medicine - Doctor of Medicine
Children's Medical Center, The - Residency - Surgery
Children's Medical Center, The - Residency - Surgery
Pharmaceutical Compositions Containing Testosterone And An Aromatase Inhibitor
US Patent:
2010014, Jun 10, 2010
Filed:
Nov 18, 2009
Appl. No.:
12/620725
Inventors:
Rebecca L. Glaser - Dayton OH, US
International Classification:
A61K 31/568, A61P 5/24
US Classification:
514171
Abstract:
A pharmaceutical dosage comprising testosterone or an ester thereof and an aromatase inhibitor; the aromatase inhibitor may be selected from the group consisting of anastrozole, letrozole, and exemestane. In one embodiment the dosage is an implant. Also disclosed are therapies for patients with symptoms of relative androgen deficiency, breast cancer survivors and other therapies in which testosterone is indicated but elevated estradiol levels are avoided.